medigraphic.com
ISSN 2221-2434 (Electronic)

2022, Number 1

<< Back Next >>

Finlay 2022; 12 (1)

Cerebrovascular Disease and Atherosclerosis in Angolan Patients

Castro IM, Castro ID, Seoane PJM, Torres PL, Aguirre CCM

Language: Spanish
References: 20
Page: 39-50
PDF size: 548.05 Kb.


ABSTRACT

Background: cerebrovascular disease is a multifactorial condition caused by a combination of vascular, environmental and genetic factors. A considerable number of genes involved in inflammation, renin-angiotensin system, and lipid metabolism have been identified. There are studies that report that African ethnicity is one of the risk factors for atherosclerosis.
Objective: to evaluate the behavior of cerebrovascular disease in Angolan patients hospitalized at the Las Praderas International Health Center in Havana.
Method: a prospective, longitudinal, descriptive study was carried out in 30 patients admitted to the Medicine Service at the Las Praderas International Health Center from January to December 2019 with the mentioned diagnosis. Clinical history data were collected. The variables analyzed were: age, sex, weight, height, body mass index, type of cerebrovascular disease, probable etiology, neurological sequelae, personal medical history, associated risk factors, medical treatment. The cerebrovascular disease classification scales and the application of the TOAST systems were applied and statistical processing was performed.
Results: there was a predominance of males in patients of African ethnicity with cerebrovascular disease. Atherothrombotic ischemic infarction and atherosclerotic risk factors such as: hypertension, alcoholism, smoking, overweight and dyslipidemia were more frequent. Overweight patients were related to the largest number of patients with atherosclerotic plaque, extracranial artery stenosis was not significant for the study.
Conclusion: it was evidenced that there is poor management of eating habits and lifestyle, associated with specific genetic factors of lipid metabolism that intervene in atherosclerotic disease.


REFERENCES

  1. García C, Martínez AE, García V, Ricaurte A, Torres I, Coral J. Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo. Univ Med Colom[Internet]. 2019[citado 17 Jun 2020];60(3):[aprox. 18p.]. Disponible en: https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/24640.

  2. Escobar V, Zaldívar M, Rodríguez G, Cabrera JC. Factores de riesgos prevalentes en pacientes ingresados por enfermedad cerebrovascular. Rev Cubana Med Mil[Internet]. 2014[citado 23 Feb 2020];43(4):[aprox. 8p.]. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-735361.

  3. Griessenauer CJ, Farrell S, Sarkar A, Zand R, Abedi V, Holland N, et al. Genetic susceptibility to cerebrovascular disease: A systematic review. J Cerebral Blood Flow Metabolism. 2018;38(11):1853-71.

  4. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019[Internet]. La Habana:Dirección Nacional de Estadísticas;2020[citado 15 Abr 2020]. Disponible en: Disponible en: https://bvscuba.sld.cu/anuario-estadistico-de-cuba/ .

  5. Wei LK, Au A, Menon S, Griffiths LR, Kooi CH, Irene L. Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and ischemic stroke: meta-analysis. J Stroke Cerebrovasc Dis. 2017;26(11):2482-93.

  6. Castro M, Castro D, Seoane J, Torres L, González A, Aguirre C. Aterosclerosis subclínica en trabajadores de una institución de salud. Rev Cubana Med[Internet]. 2020[citado 21 Mar 2021];60(3):[aprox. 15p.]. Disponible en: https://www.revmedicina.sld.cu/index.php/med/article/view/2134.

  7. Miyawaki S, Imai H, Shimizu M, Shinichi Y, Hideaki O, Akitake M, et al. Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion. Stroke. 2013;44(10):2894-7.

  8. Wang D, Wand Y, Jin Ch, Ji R, Wamg A, Gao X, et al. Asymptomatic Extracranial Artery Stenosis and the Risk of Cardiovascular and Cerebrovascular Diseases. Sci Rep. 2016;6(1):33960.

  9. Bang OY, Chung JW, Cha J, Lee MJ, Yeon JG, Ki CS, et, al. A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis. PLoS One. 2016;11(6):e0156607.

  10. Díez E. Nomenclatura de las enfermedades cerebrovasculares. Rev Ecuat Neurol[Internet]. 2001[citado 8 Oct 2020];10(3):[aprox. 10p.]. Disponible en: https://revecuatneurol.com/wp-content/uploads/2016/02/NOMENCLATURA-DE-LAS-ENFERMEDADES-CEREBROVASCULARES.pdf.

  11. Martín F, Tarducci ME, Tabares SM, Martín JJ, Sembaj A. Aplicación de los sistemas TOAST y CCS en el diagnóstico de accidente cerebrovascular isquémico. Rev Neurol Neurocir Psiquiat[Internet]. 2019[citado 8 Nov 2020];47(1):[aprox. 6p.]. Disponible en: https://www.medigraphic.com/cgibin/new/resumen.cgi?IDARTICULO=91237.

  12. Southerland AM. Clinical evaluation of the patient with acute stroke. Continuum. 2017;23(1):40-61.

  13. Bonet A, Dalfó A, Egocheaga MI. La hipertensión arterial, un factor de riesgo que no solo afecta a los hipertensos. Aten Prim[Internet]. 2002[citado 5 Mar 2020];30(3):[aprox. 3p.]. Disponible en: https://www.elsevier.es/es-revista-atencion-primaria-27-articulo-la-hipertension-arterial-un-factor-13035256.

  14. Garanty B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett. 2005;26(3):242-6.

  15. Pischon T, Boeing H, Hoffman K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105-20.

  16. Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation 2005;112(20):3030-2.

  17. Tribin K, Oro LP, Hernández I, Sánchez R, Ojeda I. Papel de los lípidos y las lipoproteínas en la aterosclerosis. CCC[Internet]. 2020[citado 12 Abr 2021];24(2):[aprox. 12p.]. Disponible en: https://www.revcocmed.sld.cu/index.php/cocmed/article/view/3518.

  18. Wintermark M, Sanelli PC, Albers GW, Bello J, Derdeyn C, Hetts SW, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of Neuro Interventional Surgery. Am J Neuro Radiol. 2013;34(11):E117-27.

  19. Penagos S, Guerrero GM, Solís R. Caracterización de la ateromatosis carotídea con ultrasonido Doppler. Anal Radiol Méx[Internet]. 2016[citado 19 Sep 2020];15(4):[aprox. 12p.]. Disponible en: https://www.medigraphic.com/pdfs/anaradmex/arm-2016/arm164g.pdf.

  20. Lee DY, Chiu JJ. Atherosclerosis and flow: roles of epigenetic modulation invascular endothelium. J Biomed Sci. 2019;26(56):234-40.




2020     |     www.medigraphic.com